Skip to main content

Advertisement

Log in

Novel corneal morphological alterations in Vogt-Koyanagi-Harada disease

  • Clinical Investigation
  • Published:
Japanese Journal of Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To determine whether visual function, especially when dependent on the anterior segment of ocular tissue, is altered during high-dose steroid treatment for Vogt-Koyanagi-Harada disease (VKH).

Study design

Retrospective case series

Methods

This case series included 18 eyes of 18 patients with VKH who received high-dose steroid therapy as initial treatment. All patients underwent anterior swept-source optical coherent tomography (CASIA-2) examinations during their clinical course to measure the central corneal thickness (CCT), average central corneal power (ACCP), maximum curvature (Kmax) and anterior chamber depth (ACD).

Results

The treatment duration was classified into the initial phase (earliest initial phase eIP; 0–1 month, initial phase: IP; 1–3months), middle phase (MP; 3–6 months), and late phase (LP; 6–9 months). The CCT decreased significantly after treatment (eIP vs. IP, p<0.01, eIP vs. MP, p<0.01; eIP vs. LP, p<0.01). The CCT at eIP was correlated with the flare value at 0M (R2=0.22). The change in Kmax at MP and LP was correlated with the flare value at 0M. Moreover, CCT at MP was correlated with rate of change in nasal angle open distance (AOD) at IP and rate of change in temporal AOD at IP.

Conclusions

This study was the first to reveal morphological changes in the anterior segment of the eye in VKH using CASIA-2, which may affect visual acuity and the astigmatic axis. It is vital to assess corneal morphology to determine the cause of visual function deterioration in patients with VKH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Umazume A, Ohguro N, Okada AA, Namba K, Sonoda KH, Tsuruga H, et al. Prevalence and incidence rates and treatment patterns of non-infectious uveitis in Japan: real-world data using a claims database. Jpn J Ophthalmol. 2021;65:657–65.

    Article  Google Scholar 

  2. Sonoda KH, Hasegawa E, Namba K, Okada AA, Ohguro N, Goto H, et al. Epidemiology of uveitis in Japan: a 2016 retrospective nationwide survey. Jpn J Ophthalmol. 2021;65:184–90.

    Article  Google Scholar 

  3. Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol. 2000;165:7323–9.

    Article  CAS  Google Scholar 

  4. Yamaki K, Kondo I, Nakamura H, Miyano M, Konno S, Sakuragi S. Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats. Exp Eye Res. 2000;71:361–9.

    Article  CAS  Google Scholar 

  5. Iwahashi C, Okuno K, Hashida N, Nakai K, Ohguro N, Nishida K. Incidence and clinical features of recurrent Vogt-Koyanagi-Harada disease in Japanese individuals. Jpn J Ophthalmol. 2015;59:157–63.

    Article  Google Scholar 

  6. Maruyama K, Noguchi A, Shimizu A, Shiga Y, Kunikata H, Nakazawa T. Predictors of recurrence in Vogt-Koyanagi-Harada disease. Ophthalmol Retina. 2018;2:343–50.

    Article  Google Scholar 

  7. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–52.

    Article  CAS  Google Scholar 

  8. Hirose S, Saito W, Yoshida K, Saito M, Dong Z, Namba K, et al. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2008;86:902–7.

    Article  Google Scholar 

  9. Takahashi H, Takase H, Terada Y, Mochizuki M, Ohno-Matsui K. Acquired myopia in Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2019;39:521–31.

    Article  Google Scholar 

  10. Nakai K, Gomi F, Ikuno Y, Yasuno Y, Nouchi T, Ohguro N, et al. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol. 2012;250:1089–95.

    Article  Google Scholar 

  11. Inomata H, Sakamoto T. Immunohistochemical studies of Vogt-Koyanagi-Harada disease with sunset sky fundus. Curr Eye Res. 1990;9(Suppl):35–40.

    Article  Google Scholar 

  12. Rao NA, Marak GE. Sympathetic ophthalmia simulating vogt-Koyanagi-Harada’s disease: a clinico-pathologic study of four cases. Jpn J Ophthalmol. 1983;27:506–11.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

The professional English editing was performed by Editage (https://www.editage.jp/?medium=ppc&source=rbsp).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kazuichi Maruyama.

Ethics declarations

Conflicts of interest

Y. Hamano, None; K. Maruyama, None; Y. Oie, None; N. Maeda, None; S. Koh, None; N. Hashida, None; K. Nishida, None.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Corresponding Author: Kazuichi Maruyama

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hamano, Y., Maruyama, K., Oie, Y. et al. Novel corneal morphological alterations in Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 66, 358–364 (2022). https://doi.org/10.1007/s10384-022-00914-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10384-022-00914-3

Keywords

Navigation